MRSN icon

Mersana Therapeutics
MRSN

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $236M invested in Mersana Therapeutics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$114M
2
+$28.3M
3
+$23.9M
4
RSCM
Rock Springs Capital Management
Maryland
+$21.3M
5
PAI
ProQuest Associates IV
Florida
+$13.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$114M
2
$28.3M
3
$23.9M
4
$21.3M
5
$13.4M
6
$11.4M
7
$4.89M
8
$4.76M
9
$2.85M
10
$1.75M
11
$1.51M
12
$1.11M
13
$1.05M
14
$989K
15
$853K
16
$754K
17
$699K
18
$699K
19
$676K
20
$489K
21
$279K
22
$279K
23
$279K
24
$179K
25
$70K
1
2